CRSP icon

CRISPR Therapeutics

179 hedge funds and large institutions have $1.01B invested in CRISPR Therapeutics in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 39 closing their positions.

Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
4.1%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
44
Increased
49
Reduced
40
Closed
39
Calls
$20.2M
Puts
$46.7M
Net Calls
-$26.5M
Net Calls Change
+$30.6M
Name Holding Trade Value Shares
Change
Shares
Change %
CC
26
Casdin Capital
New York
$9.76M
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$8.99M +$136K +3,061 +2%
TCM
28
Tekla Capital Management
Massachusetts
$7.91M
LCM
29
Laurion Capital Management
New York
$7.66M +$7.66M +172,725 New
ACA
30
Avoro Capital Advisors
New York
$6.54M +$6.54M +147,368 New
Capital International Investors
31
Capital International Investors
California
$6.12M +$6.12M +138,000 New
MIM
32
Monashee Investment Management
Massachusetts
$4.88M
CAI
33
Capital Advisors Inc
Oklahoma
$4.77M +$44K +991 +0.9%
AG
34
Artal Group
Luxembourg
$4.44M +$2.22M +50,000 +100%
LOAMU
35
Lombard Odier Asset Management (USA)
New York
$4.44M +$4.44M +100,000 New
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$4.43M +$326K +7,350 +8%
First Trust Advisors
37
First Trust Advisors
Illinois
$4.14M +$368K +8,295 +10%
Jane Street
38
Jane Street
New York
$3.89M +$3.44M +77,674 +780%
NIP
39
Nicholas Investment Partners
California
$3.83M -$12.4K -280 -0.3%
UBS Group
40
UBS Group
Switzerland
$3.62M -$43.1K -971 -1%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$3.4M +$1.01M +22,866 +42%
Millennium Management
42
Millennium Management
New York
$2.98M +$2.98M +67,179 New
Allianz Asset Management
43
Allianz Asset Management
Germany
$2.65M -$2.91M -65,632 -52%
WM
44
WS Management
Florida
$2.53M
Vanguard Group
45
Vanguard Group
Pennsylvania
$2.31M +$142K +3,200 +7%
Goldman Sachs
46
Goldman Sachs
New York
$2.2M -$108K -2,428 -5%
Ameriprise
47
Ameriprise
Minnesota
$2.15M -$173K -3,902 -7%
Korea Investment Corp
48
Korea Investment Corp
South Korea
$2.12M -$350K -7,900 -14%
GIM
49
Granahan Investment Management
Massachusetts
$2.1M -$2.1M -47,449 -50%
IIM
50
Ipswich Investment Management
Massachusetts
$2.06M -$473K -10,675 -19%